Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lunai Bioworks

1.42
0.0000
Volume:- -
Turnover:- -
Market Cap:32.91M
PE:-0.13
High:1.42
Open:1.42
Low:1.42
Close:1.42
52wk High:21.00
52wk Low:1.13
Shares:23.18M
Float Shares:15.00M
Volume Ratio:1.15
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.8000
EPS(LYR):-10.7843
ROE:-321.81%
ROA:-13.53%
PB:-1.54
PE(LYR):-0.13

Loading ...

Lunai Bioworks Inc. Announces Landmark Study Identifying Prognostic Biomarkers in Duchenne Muscular Dystrophy

Reuters
·
Oct 16

Lunai Bioworks Announces 10-for-1 Reverse Stock Split, Trades Under New Ticker "LNAI

Reuters
·
Sep 30

Lunai Bioworks Reports Fiscal 2025 Net Loss of $178.0 Million, No Sales Revenue Recorded; Net Loss Increases 101% Year-on-Year

Reuters
·
Sep 30

BioSymetrics, Subsidiary of Lunai Bioworks Inc., Advances AI-Driven Parkinson’s Biomarker Discovery Program

Reuters
·
Sep 25

Lunai Bioworks Inc. Announces 1-for-10 Reverse Stock Split Effective September 29, 2025

Reuters
·
Sep 25

Lunai Bioworks Subsidiary BioSymetrics and Brigham and Women's Hospital Secure $1.85M NIH STTR Grant to Develop AI-Driven Platform for Alcohol Use Disorder Therapeutics

Reuters
·
Sep 11

Lunai Bioworks Unveils Innovative AI Platform to Enhance Drug Discovery and Strengthen Biodefense Safeguards

Reuters
·
Sep 09

Lunai Bioworks Streamlines European Operations Amid Gedi Cube B.V. Bankruptcy, Reaffirms Growth Commitment

Reuters
·
Sep 08

Lunai Bioworks Inc - Gedi Cube B.v. Declared Bankrupt by Court of Amsterdam - SEC Filing

THOMSON REUTERS
·
Sep 06

Lunai Bioworks Inc. Faces Financial Setback as Subsidiary Gedi Cube B.V. Declares Bankruptcy

Reuters
·
Sep 06

Lunai Bioworks Inc. Partners with American Defense International to Enhance U.S. Biodefense Capabilities

Reuters
·
Sep 04

Renovaro Inc. Renamed to Lunai Bioworks Inc.; Effective August 20, 2025

Reuters
·
Aug 27

Renovaro Inc. Granted Extension by Nasdaq to Hold Annual Shareholder Meeting, Aiming for Compliance by October 31, 2025

Reuters
·
Aug 06

Renovaro Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jul 31

Renovaro Inc. Expands AI Patent Portfolio with New Allowances to Strengthen Position in Biomedical Sector

Reuters
·
Jul 28

Renovaro Inc - Maurice Van Tilburg Resigns as Chairman of Renovaro Inc. - SEC Filing

THOMSON REUTERS
·
Jul 26

Renovaro Inc. Announces Resignation of Chairman Maurice van Tilburg, Effective August 22, 2025

Reuters
·
Jul 26

Renovaro Inc. Announces Date for Virtual Special Meeting of Stockholders

Reuters
·
Jul 19

Renovaro Inc. Announces Breakthrough Preclinical Study Validating Genetically Engineered Dendritic Cell Therapy for Pancreatic and Solid Tumors

Reuters
·
Jul 17

Renovaro Inc. Faces Nasdaq Compliance Challenge Over Missed Shareholder Meeting Deadline

Reuters
·
Jul 14